Cholangiocarcinoma-What Level of Evidence Should We Have?

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 1-2

  Abrams, Ross A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL DECISION MAKING; EDITORIAL; ESOPHAGUS CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER CELL CARCINOMA; LYMPHADENECTOMY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; STOMACH CANCER; SURVIVAL TIME; TREATMENT PLANNING; ULCERATIVE COLITIS;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; TREATMENT OUTCOME;

EID: 57649087650     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.041     Document Type: Editorial

References (10)

1. Nelson J.W., Ghafoori A., Willett C.G., et al. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 73 (2009) 148-153
2. Khan S.A., Thomas H.C., Davidson B.R., et al. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
3. Malhi H., and Gores G.J. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45 (2006) 856-867
4. Hughes M.A., Frassica D.A., Yeo C.J., et al. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 68 (2007) 178-182
5. Kim S., Kim S., Bang Y., et al. The role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 54 (2003) 414-419
6. American Cancer Society. Cancer facts and figures 2008 (2008), American cancer Society, Atlanta, GA
7. Ahmed F., Perz J., Kwong S., et al. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chron Dis 5 3 (2008). http://www.cdc.gov/pcd/issues/2008/jul/07_0155htm Accessed July 31, 2008
8. Gebski V., Burmeister B., Smithers M., et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 8 (2007) 226-234
9. Macdonald J.S., Smalley S., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcibnoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
10. Csikesz NG, Simons JP, Tseng J, et al. Surgical specialization and operative mortality in hepato-pancreatic-biliary (HPB) surgery. J Gastrointest Surg. Epub ahead of print, July 19, 2008. Available at http://www.springerlink.com/content/510362271513284h/. Accessed August 4, 2008.